Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

49.14
+0.19000.39%
Volume:58.98K
Turnover:2.87M
Market Cap:6.06B
PE:13.07
High:49.16
Open:48.69
Low:48.64
Close:48.95
Loading ...

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

Zacks
·
09 Dec 2024

Is Halozyme Therapeutics (HALO) Stock Undervalued Right Now?

Zacks
·
09 Dec 2024

HALO vs. FOLD: Which Stock Is the Better Value Option?

Zacks
·
06 Dec 2024

Is Halozyme Therapeutics (HALO) Outperforming Other Medical Stocks This Year?

Zacks
·
05 Dec 2024

FDA Accepts Roche's Columvi sBLA for Expanded Use in Lymphoma

Zacks
·
05 Dec 2024

Orcadian Energy Expands with HALO Acquisition

TIPRANKS
·
03 Dec 2024

Halozyme Therapeutics (NASDAQ:HALO) Seems To Use Debt Rather Sparingly

Simply Wall St.
·
28 Nov 2024

Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Halozyme (HALO) and Crinetics Pharmaceuticals (CRNX)

TIPRANKS
·
27 Nov 2024

HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up

Zacks
·
25 Nov 2024

Halozyme Therapeutics Price Target Maintained With a $68.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Nov 2024

Trending: Halozyme Drops Bid for Evotec

Dow Jones
·
23 Nov 2024

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook

Benzinga
·
23 Nov 2024

Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why

Zacks
·
23 Nov 2024

Evotec takes notice of Halozyme withdrawal, convicted in standalone strategy

TIPRANKS
·
23 Nov 2024

BRIEF-Evotec Has Taken Notice Of Statement Made By Halozyme Therapeutics Inc.

Reuters
·
22 Nov 2024

Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term

Zacks
·
22 Nov 2024

Evotec's US-Listed Shares Fall 16.6%

THOMSON REUTERS
·
22 Nov 2024

Halozyme Shares Rise 4.3% After Co Withdraws Proposal to Acquire Evotec

THOMSON REUTERS
·
22 Nov 2024

Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal

Investing.com
·
22 Nov 2024

U.S.-Listed Shares of Evotec Down 19.8% Premarket

THOMSON REUTERS
·
22 Nov 2024